As Apple (AAPL) Market Value Declined, Holder Ruffer Llp Has Lowered Its Holding by $2.21 Million; Capital International Sarl Maintains Position in Seattle Genetics (SGEN)

May 22, 2018 - By Marguerite Chambers

Seattle Genetics, Inc. (NASDAQ:SGEN) Logo

Capital International Sarl increased its stake in Seattle Genetics Inc (SGEN) by 5.73% based on its latest 2017Q4 regulatory filing with the SEC. Capital International Sarl bought 8,300 shares as the company’s stock declined 4.17% with the market. The institutional investor held 153,100 shares of the health care company at the end of 2017Q4, valued at $8.19M, up from 144,800 at the end of the previous reported quarter. Capital International Sarl who had been investing in Seattle Genetics Inc for a number of months, seems to be bullish on the $8.76B market cap company. The stock decreased 0.01% or $0.005 during the last trading session, reaching $55.385. About 295,264 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has declined 20.48% since May 22, 2017 and is downtrending. It has underperformed by 32.03% the S&P500.

Ruffer Llp decreased its stake in Apple Inc (AAPL) by 1.68% based on its latest 2017Q4 regulatory filing with the SEC. Ruffer Llp sold 13,076 shares as the company’s stock declined 3.81% with the market. The institutional investor held 766,719 shares of the computer manufacturing company at the end of 2017Q4, valued at $129.75 million, down from 779,795 at the end of the previous reported quarter. Ruffer Llp who had been investing in Apple Inc for a number of months, seems to be less bullish one the $922.28 billion market cap company. The stock increased 0.01% or $0.01 during the last trading session, reaching $187.64. About 9.45M shares traded. Apple Inc. (NASDAQ:AAPL) has risen 19.49% since May 22, 2017 and is uptrending. It has outperformed by 7.94% the S&P500.

Capital International Sarl, which manages about $1.07 billion US Long portfolio, decreased its stake in Transdigm Group Inc (NYSE:TDG) by 2,300 shares to 27,750 shares, valued at $7.62 million in 2017Q4, according to the filing. It also reduced its holding in Royal Caribbean Cruises Ltd (NYSE:RCL) by 17,400 shares in the quarter, leaving it with 87,400 shares, and cut its stake in Credicorp Ltd (NYSE:BAP).

Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 9 have Buy rating, 0 Sell and 9 Hold. Therefore 50% are positive. Seattle Genetics had 67 analyst reports since July 31, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Monday, October 23 by Needham. The rating was maintained by Needham with “Buy” on Friday, September 15. Bank of America maintained the stock with “Neutral” rating in Wednesday, February 7 report. The firm has “Hold” rating given on Tuesday, October 10 by Oppenheimer. Cowen & Co maintained it with “Hold” rating and $5400 target in Monday, June 26 report. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) has “Buy” rating given on Monday, November 13 by RBC Capital Markets. The firm has “Outperform” rating given on Monday, October 10 by RBC Capital Markets. Morgan Stanley maintained the stock with “Overweight” rating in Wednesday, March 21 report. On Wednesday, July 27 the stock rating was downgraded by Cantor Fitzgerald to “Hold”. Oppenheimer maintained the stock with “Hold” rating in Monday, July 24 report.

Since December 11, 2017, it had 3 insider purchases, and 10 selling transactions for $268.25 million activity. $215,238 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) was sold by Cline Darren S. 5,000 shares were sold by HIMES VAUGHN B, worth $290,604 on Thursday, March 15. BAKER BROS. ADVISORS LP bought $51.26M worth of Seattle Genetics, Inc. (NASDAQ:SGEN) on Monday, April 30. 10,457 shares were sold by DRACHMAN JONATHAN G, worth $552,452.

More notable recent Seattle Genetics, Inc. (NASDAQ:SGEN) news were published by: Seekingalpha.com which released: “Seattle Genetics (SGEN) Q1 2018 Results – Earnings Call Transcript” on April 27, 2018, also Globenewswire.com with their article: “Factors of Influence in 2018, Key Indicators and Opportunity within Patterson Companies, Zayo Group, Six Flags …” published on May 09, 2018, Seekingalpha.com published: “Key events next week – healthcare” on April 27, 2018. More interesting news about Seattle Genetics, Inc. (NASDAQ:SGEN) were released by: Streetinsider.com and their article: “Seattle Genetics (SGEN) Announces Data Presentations at ASCO” published on May 17, 2018 as well as Businesswire.com‘s news article titled: “Seattle Genetics Appoints Roger D. Dansey, MD, Chief Medical Officer” with publication date: May 17, 2018.

Investors sentiment increased to 1.23 in Q4 2017. Its up 0.45, from 0.78 in 2017Q3. It increased, as 24 investors sold SGEN shares while 67 reduced holdings. 44 funds opened positions while 68 raised stakes. 141.83 million shares or 1.14% more from 140.23 million shares in 2017Q3 were reported. Pnc Financial Services reported 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Vantage Invest Advsrs Lc accumulated 600 shares or 0.01% of the stock. Westpac accumulated 8,304 shares. Prudential Fincl has 6,091 shares. Credit Suisse Ag holds 0.01% in Seattle Genetics, Inc. (NASDAQ:SGEN) or 134,621 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 24,753 shares. Oregon Public Employees Retirement Fund holds 15,171 shares or 0.01% of its portfolio. Bain Capital Public Equity Mngmt Ltd Company has 0.43% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 111,426 shares. Winfield Associates Inc holds 0% or 40 shares. Prelude Capital Mgmt Lc reported 0% stake. 25,900 were reported by Quantitative Investment Lc. Emory University accumulated 1.45% or 31,683 shares. First Trust Lp has invested 0.08% in Seattle Genetics, Inc. (NASDAQ:SGEN). Fairfield Bush has 0.25% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 16,772 shares. Rock Springs Capital Mngmt LP owns 125,000 shares for 0.3% of their portfolio.

More notable recent Apple Inc. (NASDAQ:AAPL) news were published by: Seekingalpha.com which released: “Apple: With Enemies Like These, Who Needs Friends?” on May 17, 2018, also Seekingalpha.com with their article: “Microsoft 3.0: A Turnaround That Looks Real” published on May 22, 2018, Seekingalpha.com published: “The Bright And The Dark Side Of Apple Valuation” on May 21, 2018. More interesting news about Apple Inc. (NASDAQ:AAPL) were released by: Nasdaq.com and their article: “Look Here for Safe High-Yield Investments and Guaranteed Returns” published on May 21, 2018 as well as Nasdaq.com‘s news article titled: “Monday Apple Rumors: Beats Line May Get Its Own HomePod” with publication date: May 21, 2018.

Among 56 analysts covering Apple Inc. (NASDAQ:AAPL), 37 have Buy rating, 1 Sell and 18 Hold. Therefore 66% are positive. Apple Inc. had 414 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Pacific Crest on Thursday, October 13 with “Overweight”. The stock of Apple Inc. (NASDAQ:AAPL) earned “Buy” rating by Guggenheim on Tuesday, January 30. The stock has “Buy” rating by Canaccord Genuity on Friday, April 20. UBS maintained Apple Inc. (NASDAQ:AAPL) rating on Friday, February 2. UBS has “Buy” rating and $190.0 target. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, April 27. As per Tuesday, February 21, the company rating was maintained by Morgan Stanley. Drexel Hamilton maintained it with “Buy” rating and $208.0 target in Tuesday, September 19 report. The company was maintained on Friday, August 28 by Piper Jaffray. The rating was maintained by Canaccord Genuity on Friday, November 3 with “Buy”. The stock has “Buy” rating by UBS on Friday, September 11.

Analysts await Apple Inc. (NASDAQ:AAPL) to report earnings on August, 7. They expect $2.19 earnings per share, up 31.14% or $0.52 from last year’s $1.67 per share. AAPL’s profit will be $10.76 billion for 21.42 P/E if the $2.19 EPS becomes a reality. After $2.73 actual earnings per share reported by Apple Inc. for the previous quarter, Wall Street now forecasts -19.78% negative EPS growth.

Investors sentiment increased to 0.73 in Q4 2017. Its up 0.03, from 0.7 in 2017Q3. It improved, as 50 investors sold AAPL shares while 1023 reduced holdings. 151 funds opened positions while 637 raised stakes. 2.98 billion shares or 0.18% more from 2.97 billion shares in 2017Q3 were reported. 383,672 are held by Omers Administration Corporation. Orrstown Financial Services accumulated 10,213 shares or 1.99% of the stock. Moreover, Eqis Cap Mngmt has 0.43% invested in Apple Inc. (NASDAQ:AAPL). Georgia-based Invesco Ltd has invested 3.02% in Apple Inc. (NASDAQ:AAPL). Proshare Ltd Limited Liability Company invested 4.04% of its portfolio in Apple Inc. (NASDAQ:AAPL). 375 were accumulated by Covenant Multifamily Offices Lc. 81,488 were accumulated by Fuller Thaler Asset Mngmt. Millennium Mgmt holds 624,432 shares or 0.15% of its portfolio. Karp Cap Management invested in 0.18% or 2,499 shares. 20,382 are owned by Blue Edge Lc. Lee Danner And Bass accumulated 147,413 shares or 2.54% of the stock. Ctc Limited Liability Corp invested in 0.03% or 122,042 shares. Glenview Management Ltd Llc invested in 1.26M shares. 12Th Street Asset Mgmt Ltd Liability Company invested 6.2% of its portfolio in Apple Inc. (NASDAQ:AAPL). Lumina Fund Mngmt Ltd stated it has 3.06% of its portfolio in Apple Inc. (NASDAQ:AAPL).

Since December 7, 2017, it had 0 buys, and 8 sales for $42.88 million activity. 39,122 shares were sold by Maestri Luca, worth $6.83 million on Thursday, April 12. The insider LEVINSON ARTHUR D sold 35,000 shares worth $6.51 million. $2.90M worth of Apple Inc. (NASDAQ:AAPL) shares were sold by WILLIAMS JEFFREY E. SCHILLER PHILIP W sold 69,491 shares worth $11.56M. AHRENDTS ANGELA J sold $6.75 million worth of Apple Inc. (NASDAQ:AAPL) on Thursday, May 3.

Ruffer Llp, which manages about $2.46B US Long portfolio, upped its stake in Goldcorp Inc New (NYSE:GG) by 537,125 shares to 2.36M shares, valued at $30.14 million in 2017Q4, according to the filing. It also increased its holding in Disney Walt Co (NYSE:DIS) by 119,426 shares in the quarter, for a total of 2.68M shares, and has risen its stake in Coty Inc (NYSE:COTY).

Seattle Genetics, Inc. (NASDAQ:SGEN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marguerite Chambers

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: